Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Distribution

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Revenue projections:

Revenue projections for CAH
Revenue projections for CAH

With CAH's revenue forecasted to drop below last year's level, investors are expected to take a cautious stance. Such declines typically affect a company's bottom line, reducing profitability and making investors hesitant to invest heavily in the company until financial performance improves.

Financial Ratios:

currentRatio 0.906000
forwardPE 17.224144
debtToEquity 0.000000
earningsGrowth 0.194000
revenueGrowth 0.188000
grossMargins 0.036950
operatingMargins 0.012330
trailingEps 6.950000
forwardEps 11.583740

CAH's Forward PE is at a healthy level, meaning the stock price is aligned favorably with earnings. This suggests that the stock isn't overpriced, providing room for growth and making it an appealing option for investors looking to capitalize on potential future gains.
Cardinal Health, Inc.'s positive earnings and revenue growth reflect an optimistic outlook for the company's future. The growth in these key areas indicates that Cardinal Health, Inc. is expected to continue expanding its business and boosting its financial performance in the coming periods.
Cardinal Health, Inc.'s forward EPS being higher than its trailing EPS points to expected growth in profitability. This suggests that the company is projected to perform better in the current financial year, with higher earnings forecasted compared to the previous year.

Price projections:

Price projections for CAH
Price projections for CAH

The stock price of Cardinal Health, Inc. has often been near the lower end of projections, indicating that it may not be meeting investor expectations. This trend could suggest challenges ahead for the company.

Insider Transactions:

Insider Transactions for CAH
Insider Transactions for CAH


5 sales of CAH stock were made, with market price at 196.502001953125 per share.There were no sell transactions during the period under consideration.The recent trend of more purchases than sales at Cardinal Health, Inc.'s current price could signal investor optimism. This pattern may point to a positive outlook for the stock, as it indicates growing confidence in its potential to perform well in the future.

Recommendation changes over time:

Recommendations trend for CAH
Recommendations trend for CAH


The analysts' recent buy bias for CAH indicates strong confidence in the stock's future performance. This could encourage more investors to view CAH as a worthwhile investment, positioning the company as a top choice for those seeking financial security and long-term growth opportunities.